Free Trial
OTCMKTS:MRVFF

Nuvo Pharmaceuticals (MRVFF) Stock Price, News & Analysis

$0.98
0.00 (0.00%)
(As of 03/16/2023)
Today's Range
$0.98
$0.98
50-Day Range
$0.98
$0.98
52-Week Range
$0.42
$1.25
Volume
N/A
Average Volume
11,250 shs
Market Capitalization
$11.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MRVFF stock logo

About Nuvo Pharmaceuticals Stock (OTCMKTS:MRVFF)

Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada.

MRVFF Stock Price History

MRVFF Stock News Headlines

Holdco Nuvo Group DG Ltd
Holdco Nuvo Group DG Ltd NUVO
Nuvo Pharmaceuticals Inc (MRVFF)
West Pharmaceutical Services Inc WST
NYMXF Nymox Pharmaceutical Corporation
MRVFF Nuvo Pharmaceuticals Inc.
Miravo Healthcare™ Special Meeting Reminder
Nuvo Pharmaceuticals; reports Q4 results
See More Headlines
Receive MRVFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuvo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:MRVFF
CIK
N/A
Employees
100
Year Founded
N/A

Profitability

Net Income
$-25,700,000.00
Pretax Margin
25.58%

Debt

Sales & Book Value

Annual Sales
$54.98 million
Cash Flow
$0.09 per share
Book Value
($0.80) per share

Miscellaneous

Free Float
10,602,000
Market Cap
$11.17 million
Optionable
Not Optionable
Beta
0.98
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Jesse F. Ledger
    President & Chief Executive Officer
  • Bernard Chiasson
    Chief Scientific Officer & VP-Operations
  • Mary-Jane E. Burkett
    Chief Financial Officer & Vice President
  • Wade Hull
    Vice President-Research & Development
  • Katina K. Loucaides
    Secretary, Vice President & General Counsel

MRVFF Stock Analysis - Frequently Asked Questions

How have MRVFF shares performed in 2024?

Nuvo Pharmaceuticals' stock was trading at $0.9795 at the beginning of the year. Since then, MRVFF stock has increased by 0.0% and is now trading at $0.9795.
View the best growth stocks for 2024 here
.

How do I buy shares of Nuvo Pharmaceuticals?

Shares of MRVFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MRVFF) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners